Abstract
The present study was undertaken to evaluate the systemic absorption and cervical tissue uptake of all-transretinoic acid (TRA), delivered via a collagen spongecervical cap delivery device in patients with intraepithelial cervical dysplasia. Ten patients with histologically proven mild or moderate cervical dysplasia were included in this pharmacologic study. The two TRA concentrations (0.05% and 0.372%) selected for study represent the starting and maximally tolerated doses used in phase I clinical trial. All-trans-retinoic-11-3H acid (3H-TRA, 500 μCi) was used to facilitate cervical tissue uptake studies. Cervical biopsies and post-treatment blood samples were obtained from each patient after TRA exposure. The uptake of TRA into cervical tissues four hours after drug administration was significantly increased at the maximally tolerated TRA dose. There was a rapid decrease in cervical tissue concentration of TRA at the 0.372% dose between 4 and 24 h after drug exposure, suggesting a relatively short elimination half-life of TRA in cervical tissues. HPLC analysis of post-treatment blood samples indicate that there was no systemic absorption of TRA after local cervical administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Saffiotti U, Montesano R, Sellakumar AR, Borg SA: Experimental cancer of the lung: Inhibition by vitamin A of the induction of trachiobronchial squamous metaplasia and squamous cell tumors. Cancer 20:857–864, 1967
Trown RW, Buck MJ, Hansen R: Inhibition of growth and regression of a transplantable rat chondrosarcoma by three retinoids. Cancer Treat Rep 60:1647–1653, 1976
Mayer H, Bollag W, Hanni R, Ruegg R: Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology. Experientia 34:1105–1119, 1978
Sporn MB, Newton DL: Chemoprevention of cancer with retinoids. Fed Proc 38:2528–2534, 1978
Bollag W, Matter A: From vitamin A to retinoids in experimental and clinical oncology: achievements, failures and outlook. Ann NY Acad Sci 359:9–23, 1981
Prutkin W: The effect of vitamin A acid on hyperkeratinization and the keratoacanthoma. J Invest Dermatol 49:165–172, 1967
Koch H: Biochemical treatment of precancerous oral lesions: the effectiveness of various analogues of retinoic acid. In: Orfanos et al. (Eds.): Retinoids: Advances in Basic Research and Therapy. 1981 pp. 308–321
Meyskens FL Jr, Graham V, Chvapil M, Dorr RT, Alberts DS, Surwit EA: A phase I trial of β-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild and moderate intraepithelial cervical neoplasia. JNCI 71:921–925, 1983
Goodman GE, Einspahr JG, Alberts DS, Davis TP, Leigh SA, Chen HS, Meyskens FL Jr: Pharmacokinetics of 13-cisretinoic acid in patients with advanced cancer. Cancer Res 42:2087–2091, 1982
Chvapil M: Collagen sponge: theory and practice of medical applications. J Biomed Mater Res 11:721–726, 1977
Werner SA, Surwit EA, Graham VE, Meyskens FL Jr: A phase I trial of topically applied trans-retinoic acid in cervical dysplasia — clinical efficacy. Invest New Drugs 4:241–244, 1986
Graham V, Surwit ES, Weiner S, Meyskens FL Jr: Phase II trial of β-all-trans-retinoic acid for intraepithelial cervical neoplasia delivered via a collagen sponge and cervical cap. Western J Medicine, In press, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peng, YM., Alberts, D.S., Graham, V. et al. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia. Invest New Drugs 4, 245–249 (1986). https://doi.org/10.1007/BF00179591
Issue Date:
DOI: https://doi.org/10.1007/BF00179591